THEO-260

· Theolytics Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for THEO-260, covering 2026-04-14 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients [Phase 1]